CWCynthia K. Wallace

Cynthia K. Wallace

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cynthia K. Wallace has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity

    by Emily A. Rosen, Shandra Truong, Elizabeth M. Krantz, Allison Thibodeau, Cynthia K. Wallace, Zahra Kassamali Escobar, Pooja Bhattacharyya, Regina Lengermann, Michelle Swetky, Salma Walji, et al.

    Background: Multiplexed polymerase chain reaction gastrointestinal panels (GIPs) include mostly community-acquired pathogens. Diagnostic yield of GIPs for detection of non- Clostridioides difficile targets in hospitalized patients with cancer with community versus hospital-onset diarrhea is not well defined. Methods: This cross-sectional study included stool tests from hospitalized adults with a cancer diagnosis from July 2021 to May 2025. Our center recommends a GIP primarily for patients with community-onset diarrhea and stand-alone C. difficile testing for hospital-onset diarrhea. Generalized estimating equations with Poisson regression were used to estimate the prevalence ratio (PR) of detecting ≥1 non- C. difficile target after hospital day (HD) 3 compared to HD 1–3. Results: Among 1,433 GIPs from 1,127 patients, 468 (33%) were ordered after HD 3. Most GIPs were among patients with hematologic malignancies (794/1,433; 55%) and of those tests 352/794 (44%) were ordered after HD 3. Among all GIPs, C. difficile and norovirus were detected most frequently (16% and 6%, respectively). A non- C. difficile target was detected after HD 3 on 49/468 GIPs (10%), compared to 146/965 (15%) GIPs on HD 1–3 (adjusted PR 0.73; 95% CI [0.53–1.00]; P = .053). Among 49 GIPs after HD 3 detecting ≥1 non- C. difficile target, 19 tests were ordered for new-onset diarrhea and only 5 of these patients received intentional antimicrobial therapy in response to the GIP result. Conclusions: The added diagnostic yield for detecting ≥1 non- C. difficile target by GIP in patients with cancer and hospital-onset diarrhea is limited and supports restricting GIP ordering after HD 3 on oncology units.

  • An Unusual Perianal Lesion: Host Defenses Gone Awry

    by Cynthia K. Wallace, Joyce Pang, Nuria Perez‐Reyes, Kara Britten, Ralph Tayyar, Robert Rakita